ArticleInternational journal of hematology2019

Impact of chromosomal abnormalities on the efficacy of lenalidomide plus dexamethasone treatment in patients with relapsed/refractory multiple myeloma.

Takashi Yoshida et al.PubMed ↗Publisher ↗

No numbers read from the abstract.